97 related articles for article (PubMed ID: 24656006)
41. [Replacement of insulin by fasting C-peptide in modified homeostasis model assessment to evaluate insulin resistance and islet beta cell function].
Li X; Zhou ZG; Qi HY; Chen XY; Huang G
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Aug; 29(4):419-23. PubMed ID: 16134594
[TBL] [Abstract][Full Text] [Related]
42. Statin therapy is associated with the development of new-onset diabetes after transplantation in liver recipients with high fasting plasma glucose levels.
Cho Y; Lee MJ; Choe EY; Jung CH; Joo DJ; Kim MS; Cha BS; Park JY; Kang ES
Liver Transpl; 2014 May; 20(5):557-63. PubMed ID: 24477986
[TBL] [Abstract][Full Text] [Related]
43. Polycystic kidney disease is a risk factor for new-onset diabetes after transplantation.
Hamer RA; Chow CL; Ong AC; McKane WS
Transplantation; 2007 Jan; 83(1):36-40. PubMed ID: 17220788
[TBL] [Abstract][Full Text] [Related]
44. Matsuda-DeFronzo insulin sensitivity index is a better predictor than HOMA-IR of hypertension in Japanese: the Tanno-Sobetsu study.
Furugen M; Saitoh S; Ohnishi H; Akasaka H; Mitsumata K; Chiba M; Furukawa T; Miyazaki Y; Shimamoto K; Miura T
J Hum Hypertens; 2012 May; 26(5):325-33. PubMed ID: 21412265
[TBL] [Abstract][Full Text] [Related]
45. KCNQ1 gene variants and risk of new-onset diabetes in tacrolimus-treated renal-transplanted patients.
Tavira B; Coto E; Díaz-Corte C; Ortega F; Arias M; Torres A; Díaz JM; Selgas R; López-Larrea C; Campistol JM; Ruiz-Ortega M; Alvarez V;
Clin Transplant; 2011; 25(3):E284-91. PubMed ID: 21355884
[TBL] [Abstract][Full Text] [Related]
46. An observational study of reduction of insulin resistance and prevention of development of type 2 diabetes mellitus in women with polycystic ovary syndrome treated with metformin and diet.
Glueck CJ; Goldenberg N; Sieve L; Wang P
Metabolism; 2008 Jul; 57(7):954-60. PubMed ID: 18555837
[TBL] [Abstract][Full Text] [Related]
47. A novel index of insulin resistance determined from the homeostasis model assessment index and adiponectin levels in Japanese subjects.
Matsuhisa M; Yamasaki Y; Emoto M; Shimabukuro M; Ueda S; Funahashi T; Matsuzawa Y
Diabetes Res Clin Pract; 2007 Jul; 77(1):151-4. PubMed ID: 17081646
[TBL] [Abstract][Full Text] [Related]
48. Diagnosis, management and treatment of glucometabolic disorders emerging after kidney transplantation: a position statement from the Nordic Transplantation Societies.
Hornum M; Lindahl JP; von Zur-Mühlen B; Jenssen T; Feldt-Rasmussen B
Transpl Int; 2013 Nov; 26(11):1049-60. PubMed ID: 23634804
[TBL] [Abstract][Full Text] [Related]
49. Magnesemia in renal transplant recipients: relation with immunosuppression and posttransplant diabetes.
Osorio JM; Bravo J; Pérez A; Ferreyra C; Osuna A
Transplant Proc; 2010 Oct; 42(8):2910-3. PubMed ID: 20970568
[TBL] [Abstract][Full Text] [Related]
50. The prevalence of insulin resistance and its relationship between anemia, secondary hyperparathyroidism, inflammation, and cardiac parameters in chronic hemodialysis patients.
Sit D; Kadiroglu AK; Yilmaz ME; Kara IH; Isikoglu B
Ren Fail; 2005; 27(4):403-7. PubMed ID: 16060127
[TBL] [Abstract][Full Text] [Related]
51. Prevalence and Predictors of "New-onset Diabetes after Transplantation" (NODAT) in Renal Transplant Recipients: An Observational Study.
Choudhury PS; Mukhopadhyay P; Roychowdhary A; Chowdhury S; Ghosh S
Indian J Endocrinol Metab; 2019; 23(3):273-277. PubMed ID: 31641626
[TBL] [Abstract][Full Text] [Related]
52. Pretransplantation Risk Factors Associated With New-onset Diabetes After Living-donor Kidney Transplantation.
Xie L; Tang W; Wang X; Wang L; Lu Y; Lin T
Transplant Proc; 2016 Dec; 48(10):3299-3302. PubMed ID: 27931572
[TBL] [Abstract][Full Text] [Related]
53. Body Fat Area as a Predictive Marker of New-Onset Diabetes Mellitus After Kidney Transplantation.
Taoka R; Tanaka K; Sofue T; Abe Y; Naito H; Miyauchi Y; Matsuoka Y; Tajima M; Kato T; Tsunemori H; Ueda N; Nishiyama Y; Minamino T; Sugimoto M; Kakehi Y
Transplant Proc; 2019 Dec; 51(10):3281-3285. PubMed ID: 31635839
[TBL] [Abstract][Full Text] [Related]
54. New onset diabetes after kidney transplantation is associated with increased mortality-A retrospective cohort study.
Cooper L; Oz N; Fishman G; Shohat T; Rahamimov R; Mor E; Green H; Grossman A
Diabetes Metab Res Rev; 2017 Nov; 33(8):. PubMed ID: 28731619
[TBL] [Abstract][Full Text] [Related]
55. New-onset diabetes after kidney transplantation: Incidence and associated factors.
Gomes V; Ferreira F; Guerra J; Bugalho MJ
World J Diabetes; 2018 Jul; 9(7):132-137. PubMed ID: 30079149
[TBL] [Abstract][Full Text] [Related]
56. Patients with persistent new-onset diabetes after transplantation have greater weight gain after kidney transplantation.
Kim Y; Kim JR; Choi H; Hwang JW; Jang HR; Lee JE; Kim SJ; Kim YG; Kim DJ; Oh HY; Huh W
J Korean Med Sci; 2013 Oct; 28(10):1431-4. PubMed ID: 24133345
[TBL] [Abstract][Full Text] [Related]
57. Twelve-Month and Five-Year Analyses of Risk Factors for New-Onset Diabetes After Transplantation in a Group of Patients Homogeneous for Immunosuppression.
Dedinská I; Laca Ĺ; Miklušica M; Galajda P; Mokáň M
Transplant Proc; 2015; 47(6):1831-9. PubMed ID: 26293059
[TBL] [Abstract][Full Text] [Related]
58. Association between anemia at three different time points and new-onset diabetes after kidney transplantation--a retrospective cohort study.
Grossman A; Ayalon-Dangur I; Cooper L; Shohat T; Rahamimov R; Mor E; Gafter-Gvili A
Endocr Res; 2018 May; 43(2):90-96. PubMed ID: 29300115
[TBL] [Abstract][Full Text] [Related]
59. Pretransplant risk score for new-onset diabetes after kidney transplantation.
Chakkera HA; Weil EJ; Swanson CM; Dueck AC; Heilman RL; Reddy KS; Hamawi K; Khamash H; Moss AA; Mulligan DC; Katariya N; Knowler WC
Diabetes Care; 2011 Oct; 34(10):2141-5. PubMed ID: 21949218
[TBL] [Abstract][Full Text] [Related]
60. Can new-onset diabetes after kidney transplant be prevented?
Chakkera HA; Weil EJ; Pham PT; Pomeroy J; Knowler WC
Diabetes Care; 2013 May; 36(5):1406-12. PubMed ID: 23613600
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
